Japan-USA Orbital Atherectomy for Calcific Coronary Lesions: COAST Study, a Harmonization by Doing Proof-of-Concept: The Japanese and US Regulatory Perspective.


Journal

Cardiovascular revascularization medicine : including molecular interventions
ISSN: 1878-0938
Titre abrégé: Cardiovasc Revasc Med
Pays: United States
ID NLM: 101238551

Informations de publication

Date de publication:
04 2022
Historique:
received: 23 08 2021
accepted: 23 08 2021
pubmed: 7 9 2021
medline: 13 4 2022
entrez: 6 9 2021
Statut: ppublish

Résumé

Regulatory approval processes for medical devices in Japan and the United States of America (US) often require similar clinical trials to establish safety and effectiveness. The Harmonization by Doing (HBD) program provides a collaborative environment for communication between regulators, academics and industry, facilitating the design and conduct of US/Japanese clinical trials supporting approval in both countries.

Identifiants

pubmed: 34483075
pii: S1553-8389(21)00623-0
doi: 10.1016/j.carrev.2021.08.020
pii:
doi:

Types de publication

Letter Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

118-119

Commentaires et corrections

Type : CommentOn

Informations de copyright

Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest Authors are employees of government regulatory agencies and have no declarations of interest.

Auteurs

Shin Iwamoto (S)

Pharmaceuticals and Medical Devices Agency, Tokyo, Japan; U.S. & Japan Medical Device Harmonization by Doing (HBD) Group, USA. Electronic address: iwamoto-shin@pmda.go.jp.

Moe Ohashi (M)

Pharmaceuticals and Medical Devices Agency, Tokyo, Japan; U.S. & Japan Medical Device Harmonization by Doing (HBD) Group, USA. Electronic address: ohashi-moe@pmda.go.jp.

Haruki Shirato (H)

Pharmaceuticals and Medical Devices Agency, Tokyo, Japan; U.S. & Japan Medical Device Harmonization by Doing (HBD) Group, USA. Electronic address: shirato-haruki@pmda.go.jp.

Mami Ho (M)

Pharmaceuticals and Medical Devices Agency, Tokyo, Japan; U.S. & Japan Medical Device Harmonization by Doing (HBD) Group, USA. Electronic address: ho-mami@pmda.go.jp.

Misti Malone (M)

U.S. Food and Drug Administration, Silver Spring, MD, USA; U.S. & Japan Medical Device Harmonization by Doing (HBD) Group, USA. Electronic address: misti.malone@fda.hhs.gov.

Kenneth Cavanaugh (K)

U.S. Food and Drug Administration, Silver Spring, MD, USA; U.S. & Japan Medical Device Harmonization by Doing (HBD) Group, USA. Electronic address: kenneth.cavanaugh@fda.hhs.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH